M. Kremenovic

Characterization of a Myeloid Activation Signature That Correlates with Survival in Melanoma Patients

A. Chan, Delphine J. Lee, Thomas Gruber, 2020, Cancers.

IL-32γ potentiates tumor immunity in melanoma

A. Ribas, M. Gilliet, Gabriel Abril-Rodríguez, 2020, JCI insight.

BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma

A. Chan, Delphine J. Lee, Thomas Gruber, 2022, Journal for ImmunoTherapy of Cancer.

Clinical and molecular insights into BCG immunotherapy for melanoma

D. Lee, M. Schenk, M. Kremenovic, 2020, Journal of internal medicine.

Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma

J. Gertsch, Thomas Gruber, M. Schenk, 2021, Cancers.